Health Kick Podcast: Fighting strokes when every second counts

Stockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast.

In this episode, Tim speaks with Argenica Therapeutics (ASX:AGN) CEO and managing director Dr Liz Dallimore.

Did you know that one in four people will suffer a stroke in their lifetime, and only 10% of them will completely recover? In other terms, 15 million people suffer a stroke each year, and 5 million of them will die.

They’re sobering facts that leave us asking ourselves: What can we do for stroke victims when every second counts?

The team at Argenica Therapeutics have been asking themselves the same question for quite some times now, and hopes to improve after-stroke care with its ARG-007 neuroprotective treatment to mitigate brain tissue death.

Listen in to hear all the details.

 

This podcast was developed in collaboration with Argenica Therapeutics, a Stockhead advertiser at the time of publishing.

 

The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions.

Related Topics

Explore more

Explore more

Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

Read The Guide